0000000000312006
AUTHOR
A. Becker
Mutation Analysis of Core Binding Factor A1 in Patients with Cleidocranial Dysplasia
SummaryCleidocranial dysplasia (CCD) is a dominantly inherited disorder characterized by patent fontanelles, wide cranial sutures, hypoplasia of clavicles, short stature, supernumerary teeth, and other skeletal anomalies. We recently demonstrated that mutations in the transcription factor CBFA1, on chromosome 6p21, are associated with CCD. We have now analyzed the CBFA1 gene in 42 unrelated patients with CCD. In 18 patients, mutations were detected in the coding region of the CBFA1 gene, including 8 frameshift, 2 nonsense, and 9 missense mutations, as well as 2 novel polymorphisms. A cluster of missense mutations at arginine 225 (R225) identifies this residue as crucial for CBFA1 function. …
370: Physical activity in patients newly listed for heart transplantation: Results from the “Waiting for a New Heart Study”
A laser ion source for trace analysis
A laser ion source has been set up which is based on resonant stepwise excitation and ionization of atomic vapor confined in an ionization chamber. Using a pulsed copper vapor/dye laser system with a high repetition rate (6.5 kHz) one expects high efficiency and high selectivity for this new type of ion source. First test experiments with lead are reported.
The regulation of trehalose metabolism in insects.
Trehalose is a non-reducing disaccharide comprising two glucose molecules. It is present in high concentration as the main haemolymph (blood) sugar in insects. The synthesis of trehalose in the fat body (an organ analogous in function to a combination of liver and adipose tissue in vertebrates) is stimulated by neuropeptides (hypertrehalosaemic hormones), released from the corpora cardiaca, a neurohaemal organ associated with the brain. The peptides cause a decrease in the content of fructose 2,6-bisphosphate in fat body cells. Fructose 2,6-bisphosphate, acting synergistically with AMP, is a potent activator of the glycolytic enzyme 6-phosphofructokinase-1 and a strong inhibitor of the gluc…